Why It Matters

The nutritional challenge is real. We have the solution.

A fundamental shift towards health awareness is reshaping how people relate to food, and the entire industry with it. Reducing excessive sugar consumption is one of its greatest challenges. Incredo gives food manufacturers a better tool to address this shift by reducing sugar while creating new opportunities to incorporate beneficial ingredients, without asking consumers to give up the foods they love.

The Scale of the Challenge

43%

of adults worldwide are overweight, and 16% are obese

390M

children and adolescents aged 5–19 are overweight or obese

12%

of the adult U.S. population is using GLP-1 medications

1 in 10

adults worldwide have diabetes — with 3–4 undiagnosed for every diagnosed case

$3T USD

predicted annual global cost of overweight and obesity by 2030

17%

increase in premium chocolate sales among GLP-1 users in 2025

Alternative sweeteners are under growing scientific scrutiny.

In 2023, the IARC classified aspartame as possibly carcinogenic to humans. Studies published in 2024 linked xylitol and erythritol to elevated cardiovascular risk. As the evidence base evolves, consumer trust in artificial sweeteners and sugar alcohols continues to erode.

Incredo offers a fundamentally different path: no artificial sweeteners, no sugar alcohols, no compromise. Just real sugar working smarter.

A Large and Evolving Market

$120B+

The global sweetener market today. Sugar alternatives represent $20B, 17% of the total.

2x growth

Sugar alternatives are expected to reach $40Bn by 2035, driven by health demand and regulatory pressure.

Despite strong adoption

Existing sugar alternatives require trade-offs across taste, functionality, or labeling. The gap between consumer expectation and available solutions remains wide, and is exactly where Incredo operates.

In the News

May 2023

•

WHO

WHO advises not to use non-sugar sweeteners for weight control in newly released guideline

Read More

June 2024

Sugar substitute xylitol linked to increased risk of heart attack, stroke

Read More

October 2025

Incredo names CEO and chair

Read More

February 2023

Cleveland Clinic Study Finds Common Artificial Sweetener Linked to Higher Rates of Heart Attack and Stroke

Read More

July 2023

Aspartame hazard and risk assessment results released

Read More
Visit the Media Center